Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Glob Health J ; 7(2): 78-86, 2023 Jun.
Article in English | MEDLINE | ID: covidwho-2310409

ABSTRACT

The purpose of this review is to identify prevalent trends and risk factors in depression, anxiety, and eating disorders in the adolescent population in the post coronavirus disease 2019 (COVID-19) scenario. We examined the literature published on adolescent mental health since the COVID-19 pandemic. We chose to summarize studies published from 2019 to 2022, using bibliographic search tools. We developed criteria for selecting articles for our review using diagnostic indicators and keywords. Mental health conditions such as depression, anxiety and eating disorders are commonly prevalent in this population and have shown increasing rates in the past three years. Some risk factors associated with these diagnoses include reduction in social interaction, increased workloads, routine shifts, sleep quality, social media usage and parental involvement. Routines, sleep cycles, physical activity, and social media should all be considered as a part of prevention in this population. Approaches that seem to be successful include maintaining social ties and avoiding negative social media usage with harmful content. Increased global public awareness, as well as parental awareness, through media campaigns, is critical to slowing the spread of mental health challenges in adolescents and teenagers in the post-COVID-19 era.

2.
Subst Abus ; 42(2): 148-152, 2021.
Article in English | MEDLINE | ID: covidwho-1182932

ABSTRACT

The novel coronavirus has thrown large sections of our healthcare system into disarray, with providers overburdened by record breaking number of hospitalizations and deaths. The U.S., in particular, has remained the nation with one of the fastest growing case counts in the world. As a consequence, many other critical healthcare needs have not received the necessary resources or consideration. This commentary draws attention to substance use and opioid access during the ongoing crisis, given the potential for breakdowns in treatment access for addiction, the growing concern of mental health comorbidities, and the lack of access for those who require opioids for adequate pain management. Further, the commentary will offer policy and practice recommendations that may be implemented to provide more equitable distribution of care.


Subject(s)
Analgesics, Opioid/therapeutic use , COVID-19 , Health Services Accessibility , Opioid-Related Disorders/drug therapy , Practice Guidelines as Topic , Public Policy , Alcoholism , Buprenorphine/therapeutic use , Electronic Health Records , Harm Reduction , Humans , Internet of Things , Opiate Overdose/prevention & control , Opiate Substitution Treatment/methods , Opioid Epidemic , Pain Management , Palliative Care , Psychosocial Support Systems , SARS-CoV-2 , Telemedicine , United States , United States Substance Abuse and Mental Health Services Administration
3.
Health Equity ; 5(1): 135-139, 2021.
Article in English | MEDLINE | ID: covidwho-1132408

ABSTRACT

Objective: The seven-vaccine series protects infants from several preventable diseases, yet disparities in its use remain in the United States. Methods: We assessed the seven-vaccine immunization rate and its predictors in infants 19-35 months using the National Immunization Survey from 2009 to 2018. Results: The seven-vaccine series rate was 72.8%, well short of the healthy people 2020 target of 90%. African American infants, infants born to mothers with less than high school education, and infants in families with an income below poverty were less likely to get the complete series. Conclusion: Disparities still exist in protecting infants from preventable diseases in the United States.

SELECTION OF CITATIONS
SEARCH DETAIL